Document is current
Any future updates will be listed below
-
Authors
Piella, Elisa Maria https://orcid.org/0000-0002-0706-3632
Chiarandon, Alberto Mario
Albanese, Maria
Puddu, Enrica Maria
Pistoia, Francesca
Saporito, Gennaro
Altieri, Marta
Giuliani, Giada
Vaghi, Gloria
Sances, Grazia
Munafò, Antonio
Chiarugi, Alberto
Ornello, Raffaele
De Santis, Federico
Valente, Mariarosaria
Rao, Renata
Russo, Antonio
Silvestro, Marcello
Roveta, Fausto
Montisano, Danilo Antonio
Grazzi, Licia
Battistini, Stefania
Boscain, Francesca
Mampreso, Edoardo
Paolicelli, Damiano
Sacco, Simona
Tassorelli, Cristina
Rubino, Elisa
Prudenzano, Maria Pia
Rainero, Innocenzo
,
Ferrandes, Fabio
Zucca, Milena
Centonze, Diego
D’Agostino, Vittoria Carla
Zilli, Chiara
De Icco, Roberto
Corrado, Michele
Taglialatela, Antonio
Tereshko, Yan
Gentile, Martino
-
Funding
Funding for this research was provided by:
Università degli Studi di Torino
- License Information
-
More Information
Article History
Received: 7 March 2026
Accepted: 3 April 2026
First Online: 17 April 2026
Declarations
:
: None
: MA received financial support, consulting fees for the participation in advisory boards and support for attending meetings from: Teva, Eli Lilly, Lundbeck, Pfizer, Organon and AbbVie.
: The local Ethics committee approved the study as part of the Registro Italiano Cefalee (RICe) study (Studio RICe, 14591_oss CEAVC Studio RICe, 14591_oss and subsequent amendments). All procedures were conducted in accordance with the Declaration of Helsinki and the European Union General Data Protection Regulation (GDPR) (EU 2016/679).
: Written informed consent was obtained from all participants prior to enrollment.
